These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18775614)

  • 21. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C.
    Sebastiani G; Vario A; Guido M; Noventa F; Plebani M; Pistis R; Ferrari A; Alberti A
    J Hepatol; 2006 Apr; 44(4):686-93. PubMed ID: 16490278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological markers of liver fibrosis and activity as non-invasive alternatives to liver biopsy in patients with chronic hepatitis C and associated mixed cryoglobulinemia vasculitis.
    Sène D; Limal N; Messous D; Ghillani-Dalbin P; Charlotte F; Thiollière JM; Piette JC; Imbert-Bismut F; Halfon P; Poynard T; Cacoub P
    Clin Biochem; 2006 Jul; 39(7):715-21. PubMed ID: 16765932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [FibroTest-ActiTest for predicting liver fibrosis and inflammatory activity in Chinese patients with chronic hepatitis B].
    Gui HL; Xie Q; Wang H
    Zhonghua Gan Zang Bing Za Zhi; 2008 Dec; 16(12):897-901. PubMed ID: 19105932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin].
    Kozłowska J; Łoch T; Jabłońska J; Cianciara J
    Przegl Epidemiol; 2001; 55(4):451-8. PubMed ID: 11921731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. External validation of biochemical indices for noninvasive evaluation of liver fibrosis in HCV chronic hepatitis.
    Iacobellis A; Mangia A; Leandro G; Clemente R; Festa V; Attino V; Ricciardi R; Giacobbe A; Facciorusso D; Andriulli A
    Am J Gastroenterol; 2005 Apr; 100(4):868-73. PubMed ID: 15784034
    [No Abstract]   [Full Text] [Related]  

  • 26. Hyaluronic acid and aspartate aminotransferase levels normalized by liver function can reflect sinusoidal impairment in chronic liver disease.
    Testa E; Malfatti F; Milazzo S; Cordiviola C; Cotellessa T; Marabotto E; Giannini E; Ceppa P; Mamone M; Risso D; Testa R
    Liver Int; 2006 May; 26(4):439-44. PubMed ID: 16629647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation.
    Carrión JA; Fernández-Varo G; Bruguera M; García-Pagán JC; García-Valdecasas JC; Pérez-Del-Pulgar S; Forns X; Jiménez W; Navasa M
    Gastroenterology; 2010 Jan; 138(1):147-58.e1. PubMed ID: 19786026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study.
    Halfon P; Bourliere M; Deydier R; Botta-Fridlund D; Renou C; Tran A; Portal I; Allemand I; Bertrand JJ; Rosenthal-Allieri A; Rotily M; Sattonet C; Benderitter T; Saint Paul MC; Bonnot HP; Penaranda G; Degott C; Masseyeff MF; Ouzan D
    Am J Gastroenterol; 2006 Mar; 101(3):547-55. PubMed ID: 16542291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of FibroTest-ActiTest in children with chronic hepatitis C virus infection.
    Hermeziu B; Messous D; Fabre M; Munteanu M; Baussan C; Bernard O; Poynard T; Jacquemin E
    Gastroenterol Clin Biol; 2010 Jan; 34(1):16-22. PubMed ID: 19726147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
    D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
    Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases.
    Coco B; Oliveri F; Maina AM; Ciccorossi P; Sacco R; Colombatto P; Bonino F; Brunetto MR
    J Viral Hepat; 2007 May; 14(5):360-9. PubMed ID: 17439526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender and liver fibrosis in chronic hepatitis: the role of iron status.
    Rigamonti C; Andorno S; Maduli E; Capelli F; Boldorini R; Sartori M
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1445-51. PubMed ID: 15948811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C?
    Sebastiani G; Alberti A
    J Viral Hepat; 2012 Jan; 19 Suppl 1():18-32. PubMed ID: 22233410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis of fibrosis and cirrhosis. Liver biopsy is not always necessary.
    Prescrire Int; 2010 Feb; 19(105):38-42. PubMed ID: 20455345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
    Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies.
    Poynard T; Ngo Y; Munteanu M; Thabut D; Massard J; Moussalli J; Varaud A; Benhamou Y; Ratziu V
    Antivir Ther; 2010; 15(4):617-31. PubMed ID: 20587855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Hsu SJ; Chen CL; Hwang JJ; Lai MY; Chen PJ; Chen DS; Kao JH
    J Gastroenterol Hepatol; 2010 May; 25(5):970-7. PubMed ID: 20546452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FibroTest-ActiTest as a non-invasive marker of liver fibrosis.
    Halfon P; Munteanu M; Poynard T
    Gastroenterol Clin Biol; 2008 Sep; 32(6 Suppl 1):22-39. PubMed ID: 18973844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.
    Forns X; Ampurdanès S; Llovet JM; Aponte J; Quintó L; Martínez-Bauer E; Bruguera M; Sánchez-Tapias JM; Rodés J
    Hepatology; 2002 Oct; 36(4 Pt 1):986-92. PubMed ID: 12297848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.